{
  "functional_evidence_assessment": {
    "variant_id": [
      {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      }
    ],
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper defines that LRRK2 directly phosphorylates Akt1 at Ser473, which is crucial for cell survival and prevention of apoptosis.",
        "judgment": "Yes",
        "reasoning": "The mechanism is clearly defined as LRRK2 phosphorylating Akt1 at Ser473."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "LRRK2 phosphorylation of Akt1 was demonstrated using a protein kinase assay.",
        "judgment": "Yes",
        "reasoning": "The assay is a standard method and thus applicable."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The functional evidence for each variant (R1441C, G2019S, I2020T) supports their pathogenicity as they interfere with LRRK2's interaction with Akt1."
  }
}